When should we test for voltage-gated potassium channel complex antibodies? A retrospective case control study
- PMID: 27469409
- DOI: 10.1016/j.jocn.2016.04.021
When should we test for voltage-gated potassium channel complex antibodies? A retrospective case control study
Abstract
Patients with voltage-gated potassium channel (VGKC)-complex antibodies are increasingly recognized as having central, peripheral or combined phenotypes. With increasing awareness, more patients are tested and the clinical spectrum is expanding. Consequently, clinicians may be uncertain as to which patients should or should not be tested. Previous studies have identified common clinical features, but none has looked at the usefulness of these in predicting seropositive disease. We conducted a case-control study of patients tested for VGKC-complex antibodies over 10years at a regional tertiary neurology centre determining which clinical/biochemical features were associated with antibody-positive disease. We found a marked increase in the numbers tested, although the percentage positive remained low. Antibody titre was highest in central disease (p<0.001). Time from presentation to testing was shorter in those with VGKC-disease (p=0.01). Seizures were present in 11 (69%) of those with VGKC-disease versus three (18%) without (odds ratio [OR] 10.3, 95% confidence interval [CI]: 2.0-52.7, p=0.005). There was an inverse correlation between the antibody titre and serum sodium. A multivariate model selected seizures and hyponatraemia as predictive of VGKC disease (sensitivity 75% and specificity 82%); faciobrachial dystonic movements were specific but insensitive. Interestingly serum alkaline phosphatase was higher in those with VGKC-disease (p=0.016) and highest in those with peripheral disease (p=0.015). An ALP>70u/L was strongly associated with antibody positivity (OR 4.11 95% CI: 1.43-11.8, p=0.007) with a sensitivity of 74.2%. The presence of seizures, faciobrachial movements, and hyponatraemia should raise suspicion of VGKC-disease; alkaline phosphatase may represent a novel biomarker, particularly in those with peripheral disease.
Keywords: Autoimmune; Clinical features; Diagnosis; Encephalitis.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis.BMJ Case Rep. 2017 Apr 20;2017:bcr2016218893. doi: 10.1136/bcr-2016-218893. BMJ Case Rep. 2017. PMID: 28432047 Free PMC article.
-
An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre.J Neurol. 2015 Feb;262(2):418-24. doi: 10.1007/s00415-014-7588-0. Epub 2014 Nov 27. J Neurol. 2015. PMID: 25428531
-
Voltage-gated potassium channel antibody-associated limbic encephalitis.Age Ageing. 2014 Jul;43(4):583-5. doi: 10.1093/ageing/afu064. Epub 2014 Jun 6. Age Ageing. 2014. PMID: 24907351
-
From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.Autoimmun Rev. 2016 Oct;15(10):970-4. doi: 10.1016/j.autrev.2016.07.018. Epub 2016 Jul 30. Autoimmun Rev. 2016. PMID: 27485013 Review.
-
Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes.Handb Clin Neurol. 2016;133:185-97. doi: 10.1016/B978-0-444-63432-0.00011-6. Handb Clin Neurol. 2016. PMID: 27112678 Review.
Cited by 2 articles
-
Update on the diagnosis and management of autoimmune encephalitis.Clin Med (Lond). 2020 Jul;20(4):389-392. doi: 10.7861/clinmed.2020-0241. Clin Med (Lond). 2020. PMID: 32675144 Free PMC article.
-
Autoimmune Limbic Encephalitis in a Patient with Acute Encephalopathy and Hyponatremia.Case Rep Med. 2019 Oct 7;2019:9051738. doi: 10.1155/2019/9051738. eCollection 2019. Case Rep Med. 2019. PMID: 31687029 Free PMC article.
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources